157 related articles for article (PubMed ID: 23474920)
1. Suppression of Toll-like receptor 4 activation by endogenous oxidized phosphatidylcholine, KOdiA-PC by inhibiting LPS binding to MD2.
Kim MJ; Choi NY; Koo JE; Kim SY; Joung SM; Jeong E; Lee JY
Inflamm Res; 2013 Jun; 62(6):571-80. PubMed ID: 23474920
[TBL] [Abstract][Full Text] [Related]
2. Oxidized phospholipid inhibition of toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition.
Erridge C; Kennedy S; Spickett CM; Webb DJ
J Biol Chem; 2008 Sep; 283(36):24748-59. PubMed ID: 18559343
[TBL] [Abstract][Full Text] [Related]
3. Suppression of Toll-like receptor 4 activation by caffeic acid phenethyl ester is mediated by interference of LPS binding to MD2.
Kim SY; Koo JE; Seo YJ; Tyagi N; Jeong E; Choi J; Lim KM; Park ZY; Lee JY
Br J Pharmacol; 2013 Apr; 168(8):1933-45. PubMed ID: 23231684
[TBL] [Abstract][Full Text] [Related]
4. The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF.
Figueroa L; Xiong Y; Song C; Piao W; Vogel SN; Medvedev AE
J Immunol; 2012 May; 188(9):4506-15. PubMed ID: 22474023
[TBL] [Abstract][Full Text] [Related]
5. Glycyrrhizin and isoliquiritigenin suppress the LPS sensor toll-like receptor 4/MD-2 complex signaling in a different manner.
Honda H; Nagai Y; Matsunaga T; Saitoh S; Akashi-Takamura S; Hayashi H; Fujii I; Miyake K; Muraguchi A; Takatsu K
J Leukoc Biol; 2012 Jun; 91(6):967-76. PubMed ID: 22422925
[TBL] [Abstract][Full Text] [Related]
6. Celastrol blocks binding of lipopolysaccharides to a Toll-like receptor4/myeloid differentiation factor2 complex in a thiol-dependent manner.
Lee JY; Lee BH; Kim ND; Lee JY
J Ethnopharmacol; 2015 Aug; 172():254-60. PubMed ID: 26116162
[TBL] [Abstract][Full Text] [Related]
7. Moesin-induced signaling in response to lipopolysaccharide in macrophages.
Zawawi KH; Kantarci A; Schulze-Späte U; Fujita T; Batista EL; Amar S; Van Dyke TE
J Periodontal Res; 2010 Oct; 45(5):589-601. PubMed ID: 20546116
[TBL] [Abstract][Full Text] [Related]
8. Activation of Toll-like receptors by Burkholderia pseudomallei.
West TE; Ernst RK; Jansson-Hutson MJ; Skerrett SJ
BMC Immunol; 2008 Aug; 9():46. PubMed ID: 18691413
[TBL] [Abstract][Full Text] [Related]
9. The Fab Fragment of a Humanized Anti-Toll Like Receptor 4 (TLR4) Monoclonal Antibody Reduces the Lipopolysaccharide Response via TLR4 in Mouse Macrophage.
Cai B; Wang M; Zhu X; Xu J; Zheng W; Zhang Y; Zheng F; Feng Z; Zhu J
Int J Mol Sci; 2015 Oct; 16(10):25502-15. PubMed ID: 26512658
[TBL] [Abstract][Full Text] [Related]
10. Sulforaphane inhibits the engagement of LPS with TLR4/MD2 complex by preferential binding to Cys133 in MD2.
Koo JE; Park ZY; Kim ND; Lee JY
Biochem Biophys Res Commun; 2013 May; 434(3):600-5. PubMed ID: 23583403
[TBL] [Abstract][Full Text] [Related]
11. Arachidonic acid inhibits inflammatory responses by binding to myeloid differentiation factor-2 (MD2) and preventing MD2/toll-like receptor 4 signaling activation.
Zhang Y; Chen H; Zhang W; Cai Y; Shan P; Wu D; Zhang B; Liu H; Khan ZA; Liang G
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165683. PubMed ID: 31953218
[TBL] [Abstract][Full Text] [Related]
12. Reconstruction of LPS Transfer Cascade Reveals Structural Determinants within LBP, CD14, and TLR4-MD2 for Efficient LPS Recognition and Transfer.
Ryu JK; Kim SJ; Rah SH; Kang JI; Jung HE; Lee D; Lee HK; Lee JO; Park BS; Yoon TY; Kim HM
Immunity; 2017 Jan; 46(1):38-50. PubMed ID: 27986454
[TBL] [Abstract][Full Text] [Related]
13. Role of TLR4 tyrosine phosphorylation in signal transduction and endotoxin tolerance.
Medvedev AE; Piao W; Shoenfelt J; Rhee SH; Chen H; Basu S; Wahl LM; Fenton MJ; Vogel SN
J Biol Chem; 2007 Jun; 282(22):16042-53. PubMed ID: 17392283
[TBL] [Abstract][Full Text] [Related]
14. Soluble MD2 increases TLR4 levels on the epithelial cell surface.
Lauer S; Kunde YA; Apodaca TA; Goldstein B; Hong-Geller E
Cell Immunol; 2009; 255(1-2):8-16. PubMed ID: 18845299
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide (LPS) directly suppresses growth hormone receptor (GHR) expression through MyD88-dependent and -independent Toll-like receptor-4/MD2 complex signaling pathways.
Dejkhamron P; Thimmarayappa J; Kotlyarevska K; Sun J; Lu C; Bonkowski EL; Denson LA; Menon RK
Mol Cell Endocrinol; 2007 Aug; 274(1-2):35-42. PubMed ID: 17601656
[TBL] [Abstract][Full Text] [Related]
16. Host species-specific usage of the TLR4-LPS receptor complex.
Lizundia R; Sauter KS; Taylor G; Werling D
Innate Immun; 2008 Aug; 14(4):223-31. PubMed ID: 18669608
[TBL] [Abstract][Full Text] [Related]
17. Mice Plasmacytoid Dendritic Cells Were Activated by Lipopolysaccharides Through Toll-Like Receptor 4/Myeloid Differentiation Factor 2.
Zhang W; An EK; Hwang J; Jin JO
Front Immunol; 2021; 12():727161. PubMed ID: 34603298
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory action of 2-carbomethoxy-2,3-epoxy-3-prenyl-1,4-naphthoquinone (CMEP-NQ) suppresses both the MyD88-dependent and TRIF-dependent pathways of TLR4 signaling in LPS-stimulated RAW264.7 cells.
Ju Woo H; Jun DY; Lee JY; Park HS; Woo MH; Park SJ; Kim SC; Yang CH; Kim YH
J Ethnopharmacol; 2017 Jun; 205():103-115. PubMed ID: 28465253
[TBL] [Abstract][Full Text] [Related]
19. [Bacterial endotoxin-induced endothelial cell injury and calcium overload associated with Toll-like receptor and calcium signal].
Xiao J; Song Q; Li T; Sun R
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Feb; 29(2):150-155. PubMed ID: 28625263
[TBL] [Abstract][Full Text] [Related]
20. Synergy and cross-tolerance between toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways.
Sato S; Nomura F; Kawai T; Takeuchi O; Mühlradt PF; Takeda K; Akira S
J Immunol; 2000 Dec; 165(12):7096-101. PubMed ID: 11120839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
